Use of Methoxyflurane (Penthrox) as an Antalgic in Hospital Trauma

• Status: Completed
• Trial end date: 2020-03-11
• Target enrollment: 0
• Participant gender: All

Summary

Study of traumatized patients treated in emergency departments of Tours, seeking to optimize the management of trauma pain in an inpatient setting, with the opportunity to integrate inhaled methoxyflurane (Penthrox®) into the arsenal analgesics useful in the analgesic protocol of the Reception and Orientation Nurse.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University Hospital, Tours
• Treatments: Methoxyflurane

Criteria

Inclusion Criteria:

• Conscious patient

• Age ≥ 18 years

• Acute pain of monotraumatic origin

• Pain > 4 on a visual numerical scale

Exclusion Criteria:

• State of shock with unstable hemodynamics (PA <90/60)

• Suspected or proven trauma to the chest, abdomen or pelvis

• Serious head trauma

• Consciousness disorder with Glasgow score <15

• Patient who has already received analgesics (with the exception of paracetamol)

• Patient receiving an intravenous approach for analgesia

• Renal or hepatic disorders known

• Hypersensitivity to fluoridated anesthetics or history of malignant hyperthermia in the patient or family

• Pregnant or nursing woman

• Patient under judicial protection

• Non communicating patient or with difficulties of understanding

Exclusion Criteria:

• Intravenous injection for analgesia